WARNING: This product contains nicotine.

Nicotine is an addictive chemical.

mipodwholesale logo

Are You 21 or older?

We use 3rd party software for age-verification upon checkout. By clicking through and going to Mipodwholesale.com you agree that you are at least 21 years old.

FDA Proposes Expanded Tobacco Establishment Registration and Product Listing Requirements for Foreign Manufacturers

FDA Proposes Expanded Tobacco Establishment Registration and Product Listing Requirements for Foreign Manufacturers

Posted by Alli Boughner on Aug 4th 2026

The U.S. Food and Drug Administration (FDA) has proposed a significant update to its tobacco establishment registration and product listing regulations that would expand reporting requirements to include foreign manufacturers. If finalized, the rule would create a more comprehensive registration framework for both domestic and international tobacco product manufacturers, helping FDA maintain a more complete picture of the products entering the U.S. market. 

The proposed rule was published in the Federal Register on June 29, 2026, and is currently open for public comment. 

What Is Changing? 

Under current law, only domestic owners and operators of tobacco manufacturing establishments are required to register their facilities and submit product listings to FDA. Foreign manufacturers are generally not subject to the same requirements, creating gaps in FDA's database. 

The proposed rule would change that by requiring foreign establishments that manufacture tobacco products for the U.S. market to comply with the same registration and product listing requirements as domestic facilities. 

FDA states that complete establishment registration and product listing information is essential to support its statutory responsibilities, regulatory oversight, and public health objectives. 

What Would Manufacturers Need to Submit? 

If the proposal is finalized, both domestic and foreign manufacturers would be required to submit standardized information electronically to FDA, including: 

  • Establishment registration information  
  • Product listings for all tobacco products manufactured  
  • Ownership and operator information  
  • Manufacturing facility details  
  • Product identification information  
  • Updates when products are introduced, discontinued, or modified  

The rule also establishes standardized formats and procedures for submitting and maintaining this information. 

Why This Matters 

For years, FDA has relied on establishment registration and product listing to understand who is manufacturing tobacco products and what products are being marketed in the United States. However, the lack of registration requirements for foreign manufacturers has limited the Agency's visibility into a substantial portion of the global supply chain. 

By expanding the program internationally, FDA aims to: 

  • Improve visibility into imported tobacco products.  
  • Create a more complete product inventory.  
  • Support inspections and compliance activities.  
  • Improve supply chain transparency.  
  • Strengthen regulatory oversight.  

What This Means for the Industry 

Although the proposal does not create new product authorization requirements, it would increase administrative responsibilities for manufacturers—particularly those located outside the United States. 

Companies that manufacture products overseas for the U.S. market should begin evaluating: 

  • Whether their facilities would be subject to registration.  
  • The information needed for product listings.  
  • Internal processes for maintaining accurate records.  
  • Resources necessary to comply with ongoing reporting obligations.  

Importers and distributors working with foreign manufacturers may also want to ensure their suppliers are preparing for potential compliance requirements should the rule become final. 

Public Comment Period 

Because this is a proposed rule, no immediate action is required. FDA is currently accepting public comments before determining whether to issue a final regulation. 

Manufacturers, trade organizations, and other stakeholders have an opportunity to provide feedback on the proposed reporting requirements, implementation timelines, and potential compliance challenges. 

Looking Ahead 

While establishment registration and product listing have long been part of FDA's regulatory framework for domestic manufacturers, extending these requirements to foreign facilities would represent one of the most significant expansions of the program to date. 

Companies involved in manufacturing tobacco and nicotine products for the U.S. market should closely monitor this rulemaking process and begin assessing how expanded registration requirements could affect their operations if the proposal is finalized. 

Read the full proposed rule in the Federal Register: 
https://www.federalregister.gov/documents/2026/06/29/2026-13047/establishment-registration-and-product-listing-for-tobacco-products